Idera Pharmaceuticals Reports Third Quarter 2017 Financial Results and Provides Corporate Update
Nov 06, 2017 21:02 pm UTC| Business
– IMO 2125 Translational Data Update at SITC on November 11 –– Completes Public Offering, extends runway into second quarter 2019 – CAMBRIDGE, Mass., Nov. 06, 2017 -- Idera Pharmaceuticals, Inc. (NASDAQ:IDRA), a...
Diamondback Energy, Inc. Announces Third Quarter 2017 Financial and Operating Results
Nov 06, 2017 21:01 pm UTC| Business
MIDLAND, Texas, Nov. 06, 2017 -- Diamondback Energy, Inc. (NASDAQ:FANG) (“Diamondback” or the “Company”) today announced financial and operating results for the third quarter ended September 30, 2017. HIGHLIGHTS Q3...
Portola Pharmaceuticals Reports Third Quarter 2017 Financial Results and Provides Corporate Update
Nov 06, 2017 21:01 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., Nov. 06, 2017 -- Portola Pharmaceuticals Inc.® (Nasdaq:PTLA) will today report financial results and provide a corporate update for the quarter ended September 30, 2017. “Following FDA...
Mistras Group Announces Third Quarter Results
Nov 06, 2017 21:01 pm UTC| Business
Q3 Net Loss of ($7.0) million or ($0.25) per diluted share, including non-cash Intangible Asset Write-Off Pertaining to Products Subsidiary of ($9.8) million or ($0.33) net of tax;Excluding special items, the Company's net...
Manitex International, Inc. Provides Preliminary Summary Report on Third Quarter 2017 Operations
Nov 06, 2017 21:01 pm UTC| Business
BRIDGEVIEW, Ill., Nov. 06, 2017 -- Manitex International, Inc. (Nasdaq:MNTX) (the “Company"), a leading international provider of cranes and other specialized industrial equipment today announced that it has filed a...
Pernix Therapeutics Announces Sale of Non-Core Product
Nov 06, 2017 21:01 pm UTC| Business
MORRISTOWN, N.J., Nov. 06, 2017 -- Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX) (“Pernix” or the “Company”), a specialty pharmaceutical company, today announced the sale of a non-core product, Cedax® (ceftibuten...
ECN Capital Schedules Q3-2017 Conference Call
Nov 06, 2017 21:01 pm UTC| Business
TORONTO, Nov. 06, 2017 -- ECN Capital Corp. (TSX:ECN) (“ECN Capital” or the “Company”), one of North America’s leading finance companies, today announced that it intends to file its financial statements and management...
UK Inflation Stabilizes: November CPI at 2.6%, Signaling Economic Recovery
FDA Approval of Opdivo Injection Sparks Hope for Cancer Patients with Revolutionary Treatment Update